Women who stopped antidepressant treatment during pregnancy and resumed in the following weeks had a rebound effect of increased prescription of benzodiazepines and anxiolytics.
Post-hoc analyses of pooled data from the randomized, double-blind ASPIRE 1 and ASPIRE II studies were conducted to assess the effect of esketamine in adult patients with major depressive disorder and active suicidal ideation.
Social engagement, posttraumatic growth, optimism, and resilience are psychological factors that play an essential role in positive psychiatry.
No evidence was found to support the concerns of international drug safety authorities regarding an increased risk for suicidality in young people treated with antidepressants.
Results showed that discontinuation of any SNRI was associated with withdrawal symptoms, with the highest prevalence linked to venlafaxine and desvenlafaxine.
The use of certain antidepressants may put patients at increased risk for extrapyramidal symptoms.
Flibanserin can be safely added to a stable SSRI or SNRI regimen to treat hypoactive sexual desire disorder.
Antidepressants may effectively treat depression in patients with comorbid schizophrenia.
Minocycline has a large antidepressant effect and good tolerability compared with placebo.
Not all prescription drugs have driving impairment warnings.
